Teva Pharmaceutical Industries Limited
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Teva Pharmaceutical Industries Limited's past years’ income statements indicate that its last revenue has increased compared to the previous period by 6% to $15,846,000,000. The net income raised on -$559,000,000 and profit margin reached -4%. Total operating expenses were $4,451,000,000.

Profit Margin

Teva Pharmaceutical Industries Limited (NYSE:TEVA): Profit margin
2014 20.27B 3.05B 15.07%
2015 19.65B 1.58B 8.08%
2016 21.90B 329M 1.5%
2017 22.38B -16.26B -72.66%
2018 18.85B -2.15B -11.4%
2019 16.88B -999M -5.92%
2020 16.65B -3.99B -23.95%
2021 15.87B 417M 2.63%
2022 14.92B -2.35B -15.77%
2023 15.84B -559M -3.53%

TEVA Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
15.84B14.92B15.87B16.65B16.88B18.85B22.38B21.90B19.65B20.27B
Cost of revenue
8.2B7.95B8.28B8.93B9.35B10.55B11.56B10.04B8.29B9.21B
Gross profit
7.64B6.97B7.59B7.72B7.53B8.29B10.82B11.85B11.35B11.05B
Operating exp.
Research and development
953M838M967M997M1.01B1.21B1.84B2.11B1.52B1.48B
Selling and marketing
2.33B2.26B2.42B2.49B2.61B2.91B3.65B3.86B3.47B3.86B
Total operating expenses
4.45B4.28B4.49B4.66B4.81B5.42B6.83B7.20B6.24B6.56B
Operating income
433M2.79B3.19B3.05B2.79B-1.63B-17.48B2.15B3.35B3.95B
Other income (expenses), net
-1.05B-5.86B-2.54B-834M-4.06B-4.50B-895M-2.49B-1B-313M
Income before tax
-624M-3.06B658M-4.40B-1.26B-2.59B-18.37B824M2.35B3.63B
Income tax expense
-7M-638M211M-168M-278M-195M-1.93B521M634M591M
Net income
-559M-2.35B417M-3.99B-999M-2.15B-16.26B329M1.58B3.05B
Earnings per share
Basic EPS
-0.5-2.120.38-3.64-0.92-2.11-16.010.071.843.58
Diluted EPS
-0.5-2.120.38-3.64-0.92-2.11-16.010.071.823.56
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source